{"id":"NCT01646320","sponsor":"AstraZeneca","briefTitle":"Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Therapy With Dapagliflozin Added to Saxagliptin in Combination With Metformin Compared to Therapy With Placebo Added to Saxagliptin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin and Saxagliptin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-09","primaryCompletion":"2014-08","completion":"2015-02","firstPosted":"2012-07-20","resultsPosted":"2016-04-11","lastUpdate":"2016-06-22"},"enrollment":320,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Dapagliflozin","otherNames":[]},{"type":"DRUG","name":"Placebo matching with Dapagliflozin","otherNames":[]},{"type":"DRUG","name":"Saxagliptin","otherNames":["Onglyza"]},{"type":"DRUG","name":"Metformin immediate release (IR)","otherNames":[]}],"arms":[{"label":"Arm1: Dapagliflozin (10 mg) + Saxagliptin + Metformin IR","type":"EXPERIMENTAL"},{"label":"Arm 2: Placebo + Saxagliptin + Metformin IR","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to learn if BMS-512148 (Dapagliflozin) as part of a triple combination therapy can improve (decrease) hemoglobin A1c in patients with type 2 diabetes after 24 weeks of treatment compared to a 2 drug oral antidiabetic therapy. The safety of this treatment will also be studied.","primaryOutcome":{"measure":"Adjusted Mean Change From Baseline in Hemoglobin A1C (HbA1c) at Week 24","timeFrame":"From Baseline to Week 24","effectByArm":[{"arm":"Dapa+Saxa+Met","deltaMin":-0.82,"sd":0.0686},{"arm":"Pla+Saxa+Met","deltaMin":-0.1,"sd":0.0704}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":66,"countries":["United States","Czechia","Mexico","Poland","Puerto Rico","Romania","Russia","United Kingdom"]},"refs":{"pmids":["38770818","29802530","26246458"],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":160},"commonTop":["URINARY TRACT INFECTION","INFLUENZA","HEADACHE","DIARRHOEA","BACK PAIN"]}}